TrialCancer science2025

Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis.

Mototsugu Oya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.